오성정밀화학

비상장계속사업자

O-SUNG SPECIALTIES CO., LTD.

강무근

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

오성정밀화학

Business Reg. No. 2208103333 · CEO 강무근

I.Investment Overview

Target오성정밀화학 (2208103333)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명오성정밀화학
영문명O-SUNG SPECIALTIES CO., LTD.
대표자강무근
사업자등록번호2208103333
법인등록번호1101110554190
설립일1987.12.28
종업원수145명

V.Workforce

145

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW1,306.120211,399.720221,369.520231,282.820241,165.72025
영업이익100M KRW71.1202148.8202231.5202327.220246.42025
순이익100M KRW53.1202141.7202229.6202320.6202414.52025
Item20252024202320222021
자산총계466.2억원480.3억원502.6억원497.5억원460.3억원
부채총계163.3억원182.1억원216.3억원235.4억원235.4억원
자본총계302.8억원298.2억원286.3억원262.1억원224.9억원
매출액1,165.7억원1,282.8억원1,369.5억원1,399.7억원1,306.1억원
영업이익6.4억원27.2억원31.5억원48.8억원71.1억원
순이익14.5억원20.6억원29.6억원41.7억원53.1억원

VII.Financial Ratios

FY2025 basis

0.55%

영업이익률

1.25%

순이익률

3.12%

ROA

4.8%

ROE

53.92%

부채비율

64.97%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

오성정밀화학 투심보고서 | Alpha Lenz